Sidebar
Jun 2009

Medical Liaisons: Resource or salesperson in disguise?

Medical Laison People
I often hear stories from old timers about how drug companies used to employ salespeople who had a medical education or background. “You could often talk to these people who tended to be knowledgeable about medicine” one pharmacist told me. “Today they come in with literature and canned talks and when you want to talk with them they often tell us that we’ll have to talk to the ML”. While the number of medical liaisons has been increasing recently the real question is “Do we trust drug companies to provide ML’s as a resource or is this an attempt to sell more drugs?” Read More...
|

The real danger of not going to your doctor and undianosed conditions

PJ-AQ218_pjHEAL_DV_20090622170411
The death if Billie Mays illustrates just how quickly undiagnosed heart disease can take a life. Whether Mr Mays knew he had heart disease or high blood pressure will be open for debate but I believe this is a clear illustration of why people need to see their physician for an annual check up and follow up visits. Both drug companies and the AMA has to do a lot better job to communicate the dangers of undiagnosed medical conditions which on the surface can have no distinct symptoms until it’s too late. Read More...
|

Designing an online experience: Think about triggers and put yourself in patients place

stethkeyboard
One of the reasons that I like eMarketer so much for online information is that they give you the information you need without the fluff of some online services like Forrester which tends to give you insights from analysts who don’t have a background in healthcare. While it is important to always start with brand objectives when developing your online strategy a lot of eMarketing people often ignore the triggers of people going online for health information and what users really want when they do go online. Read More...
|

The drug industry still has a mountain to climb

images
There perhaps is no diagnosis as devastating as cancer for patients and family. Even with all of today’s medications and early detection the struggle to keep this horrible disease in check is often a long and painful journey as documented by the brave fight that Ms Farrah Fawcett waged against her cancer. The most touching moment of her documentary was when, after going through an MRI, physicians had to notify her that the cancer had spread to her liver and that additional treatments would be in vain. Until we can erase moments like these from everyone’s lives the challenge for the drug industry will be to everything it can to research and develop new medications for cancer. Read More...
|

Can for profit healthcare ever work in this country?

images
A guy who spent his career working for health-insurance companies went up to Capitol Hill today and unloaded on his former industry. “My name is Wendell Potter and for 20 years, I worked as a senior executive at health insurance companies, and I saw how they confuse their customers and dump the sick –- all so they can satisfy their Wall Street investors.” I have been saying all along that the biggest threat to consumer health is not the pharma industry but insurers and one has to wonder if the “healthcare for profit model” can ever work in a country where the dollar seems to rule our daily lives. Read More...
|

eCure Me: Why go to a doctor when you can self diagnose ?

03-frontlogo
There are an awful lot of people without health insurance and a trip to the doctor for most of these people is just not possible but an online alternative called “eCure Me” is offering patients a chance to self diagnose their medical conditions which in this authors opinion is not only dangerous but foolish. Couple self diagnosis with the increasing number of people who are sharing prescription medications and you are playing with the lives of patients who may seek reputable healthcare after it’s too late. Read More...
|

FTC: Pay for delay cost consumers over $3.5 billion a year

images
Ending settlements in which branded drug makers pay generic ones to delay entry into the market, known as “pay-for-delay” settlements, would save consumers $3.5 billion a year, plus “significant savings” for the federal government, according to Federal Trade Commission Chairman Jon Leibowitz via the Health Blog in the WSJ. Mr Leibowitz has set a priority of the FTC to stop such deals and he is urging Congress to pass legislation to restrict patent protection on prescription drugs. What does this mean for patients? It means less expensive drugs but it could also mean that the number of new drugs in development is narrowed as drug companies face increases pressure on revenue and R&D costs. Read More...
|

Physicians: We're concerned that too many people are self diagnosing

images
The most recent research that we conducted for a client finished over the weekend and we got an earful from physicians and use of the Internet for patients to self diagnose. “I’m seeing more and more patients come in saying I believe I have this and want this to treat it” said one doctor while another said “there is way too much bad information out there, how the hell are my patients supposed to know what is credible and what is now?” When asked about drug company product sites physicians said they were pretty neutral except when the site is “overly promotional”. Read More...
|

Why can't drug companies implement more social media programs?

images
People all over the Internet are asking the same thing “why doesn’t pharma implement more social media programs”? It’s a good question but unless you have worked in big pharma it’s one that i hard to answer and even harder to understand. Here are the top reasons that I believe pharma does not really embrace and integrate social media programs into their marketing. Read More...
|

Sicko revisited

I just had a chance to watch again Michaal Moore’s Sicko and although Mr Moore can be a blowhard he raises some very good points. According to what I have read the US spends more per person on health care and gets less than any other country. All you have to do is enter the complicated world of healthcare to see how the system is choking on itself and how it prevents some patients from getting good quality healthcare.

screenshot_01

Read More...
|

Who do you trust when it comes to drug approval and safety?

images-1
This week I wrote about the Gardasil page on Facebook and there seems to be quite a discussion going on within the comments sections not to mention the eMails I have received. First let me say that there is a lot of misinformation out there when it comes to the safety and efficacy of Gardasil. Some websites and videos border on criminal with misinformation and twisting of facts to scare people while other claims have no basis in data but still people need someone to blame when it comes to an illness that seems to have no cause. Here are some facts when it comes to Gardasil... Read More...
|

Paying physicians for their time or hearts?

images
Medical device maker Medtronic Inc. says it paid nearly $800,000 over the past three years to a former Army surgeon accused of fabricating a study that reported positive results for one of the company's key spine products. That’s a lot of money but when a physician is paid this much shouldn’t everything he/she does be scrutinized more instead of less? It seems that in the medical device arena this is indeed a common practice and it’s time for the FDA to establish some guidelines for payments to physicians from medical device companies. Read More...
|

Gardasil embraces social media with Facebook presence

screenshot_07
There are ways to use social media right and ways not to use social media. It all starts with the business objectives and one of the business objectives for Gardasil is to raise awareness and bring women together to fight cervical cancer. Gardasil’s Facebook page is well done, informative and let’s women connect with each other to fight cervical cancer. Fair balance is included on the home page and Gardasil does not try and disguise the fact that this is a Facebook page by a drug company. Is it working? Well it has over 100,000 followers and only time will tell but it’s a great first entry marketing attempt into social media. Read More...
|

Does President Obama really understand costs of today's healtcare?

images-1
On Monday, June 15, Obama went to Chicago to speak at a meeting of the American Medical Assn., the nation's largest physician organization. It was the first time in 26 years that a President has addressed the group. Obama's message: Any health-care reform bill will have to change the way doctors are reimbursed. That is, they could end up making less money, not exactly what you want to hear but does the President really understand that there are lot of physicians who are struggling to make ends meet because of the high cost of malpractice insurance and other practice operational costs? Read More...
|

How do people really feel about the drug indsutry?

images
I have had the pleasure of writing this BLOG for over three years now and have really enjoyed it as healthcare marketing is a passion of mine. I have tried to be objective and call for heads to roll when mistakes are made, i.e. the mess with Seroquel, but I also believe that at times the drug industry has caught between a rock and a hard place. I want to list the principles which I believe here so that everyone who reads my BLOG will have a clear understanding of where I stand. Read More...
|

The law: the facts matter and releasing "selected" information is nothing short of slimy

Llly
There was the headline on Huffington Post.com “Drug Pusher” with a big picture of Lilly’s corporate headquarters and Zyprexa. The story, from Blomberg News, is further indication that reporters today are shallow at looking up facts and that lawyers will do anything they can to try courses in the media to get a big payday. However let’s look at the facts here which is ironic because the law should be about the facts. Read More...
|

And how do feel working for a drug company?

images-1
It’s easy to be on the outside and throw arrows at those on the inside when it comes to old news and past marketing practices but if you work in the drug industry and you see these so called “journalists” constantly promoting negative information how does that make you feel? I’m not going to pretend that the drug industry is squeaky clean, there have been some really bad mistakes that have been made, but I for one am leading a more healthier life because of the prescription drugs I take. In the end a company is made up of people who are guided by leadership of the organization. The mistakes of the past and present are due to a failure of leadership at all levels of the company. Read More...
|

Has the social media wave passed by already?

images
A poll of over 100,000 on CNN.com indicated that 75% users are getting tired of social media. While the poll is unscientific and raw it shows that the attention span of the public is really poor when it comes to the Internet and that the buzz around social media may be more hype than reality. While pharma DTC marketers and the FDA try and come up with social media guidelines the social media trend may be passing by and crashing to the shore with little noise. Read More...
|

DTC: How low can it go and where should current budgets go?

Change in 2009 Marketing Budgets
John Mack recently posted an article on the results of his survey on just how much DTC funds are going to be cut and it’s not pretty. Based on the people within the industry that I have talked to however they are not only looking at cut budgets but they are making frantic phone calls to their market research people to justify the dollars they already have. Most business executives don’t have a marketing background and to them marketing is an expense that adds little value so of course when sales start to slow down it’s easy to say “cut marketing”. Read More...
|

New iPhone application allows physicians to monitor patients remotely

A new application for iPhone 3,0 software, which will be released later this month is called Airstrip. It will allow physicians to monitor patients vital signs via the iPhone remotely and will surely lead to more applications for the HCP market.

screenshot_02

|

Men: An overlooked osteoporosis market?

images
My brother gave me some troubling news this weekend. It seems that he has severe osteoporosis in his hip to which his physician immediately prescribed generic Fosamax and a regimen of Vitamin D to get his T score down. Today, 2 million American men have osteoporosis, and another 12 million are at risk for this disease. Yet, despite the large number of men affected, osteoporosis in men remains underdiagnosed and underreported. Granted this is a small market compared to women who have osteoporosis but the fact remains that men too are at risk for osteoporosis. Is this market too small for DTC marketers and there is too much education that needs to happen to get physicians to screen men for osteoporosis or is this a potential untapped market? Read More...
|

Note to Glaxo: You conduct clinical studies to answer questions not raise more issues

avandia_CV_20090605172305.jpg
A study on Avandia "provides important and reassuring information about Avandia for physicians fighting diabetes," said Ellen Strahlman, Glaxo's chief medical officer. But a large clinical study designed to test whether GlaxoSmithKline PLC's diabetes drug Avandia can be harmful to the heart appears to have raised more questions than it has answered, with some physicians calling the study flawed. So the question becomes, forget the data, forget the study, if you're a physician are you comfortable prescribing Avandia? My guess the answer to that would be no.

The bottom line is that physicians who were comfortable prescribing Avandia will continue to do so while those who have issues/questions will not. The latest clinical trial raises more questions than it answers.



Read More...
|

Women and social media: A natural evolution of Internet platforms for a strong sense of community

103490
When I launched Sararem.com one thing became apparent via research: women were open to sharing informations and wanted a platform to talk with each other. As a result, and as part of Sarafem.com, I launched a message board that soon became the top page within the site. According to a report from eMarketer 75% of female Internet users participated in social media as of March of this year. That's a really big number and pharma marketers would do well to try and harness the power of the community to help them spread the work about healthcare treatment options. Read More...
|

Prescription drug prices: Educate the public on drug assistance programs

screenshot_03
Interesting article in this morning Times which generally, judging from past articles, wants socialized prescription drugs for patients along with a watchdog adversarial FDA. In summary the article reports on how a lot of patients, mostly in low fixed incomes, are having to chose which prescription drugs are most important because they can't afford all of them. So what we are learning is that it is not necessarily to cost of branded prescription drugs that is preventing some people from taking their medications it is the cost of generic medications as well. People in lower incomes cannot afford to pay generic costs. Someone in Washington had better read this because unless something is done, and done soon, these people are going to wind up costing the healthcare system more later than preventative care now. Read More...
|

Bing's health searches provide a great user experience

Bing.com, the new search engine from Microsoft, was launched this week with a lot of buzz. While it remains to be seen if consumers are willing to learn something new in gathering information Bing does have some unique properties for searches of health information and may, just may, give Google a run for its money

.screenshot_04

Read More...
|